Form 4 • Statement of Changes in Beneficial Ownership
Type
Sell
Net shares
-197,855
% of shares
-12.73%
Amount (USD)
$2,629,888
Insider confidence score
37.5 out of 100
Positive
Negative
Security
Common Stock
Action
Exercise
Date
2026-03-02
Code
M
Net shares
+197,855.0
Price per Share
$0.34
Amount (USD)
$66,281.43
Acquired/Disposed
Acquired
Shares Owned Before
1,356,646.0
Shares Owned After
1,554,501.0
Security
Common Stock
Action
Sell
Date
2026-03-02
Code
S
Net shares
-197,855.0
Price per Share
$13.29
Amount (USD)
$2,629,888.66
Acquired/Disposed
Disposed
Shares Owned Before
1,554,501.0
Shares Owned After
1,356,646.0
Security
Common Stock
Action
Exercise
Date
2026-03-03
Code
M
Net shares
+160,567.0
Price per Share
$0.34
Amount (USD)
$53,789.95
Acquired/Disposed
Acquired
Shares Owned Before
1,356,646.0
Shares Owned After
1,517,213.0
Security
Common Stock
Action
Exercise
Date
2026-03-03
Code
M
Net shares
+33,264.0
Price per Share
$4.35
Amount (USD)
$144,764.93
Acquired/Disposed
Acquired
Shares Owned Before
1,517,213.0
Shares Owned After
1,550,477.0
Security
Stock Option (Right to Buy)
Action
Exercise
Date
2026-03-02
Code
M
Net shares
-197,855.0
Acquired/Disposed
Disposed
Shares Owned Before
358,422.0
Shares Owned After
160,567.0
Security
Stock Option (Right to Buy)
Action
Exercise
Date
2026-03-03
Code
M
Net shares
-160,567.0
Acquired/Disposed
Disposed
Shares Owned Before
160,567.0
Shares Owned After
0.0
Security
Stock Option (Right to Buy)
Action
Exercise
Date
2026-03-03
Code
M
Net shares
-33,264.0
Acquired/Disposed
Disposed
Shares Owned Before
224,956.0
Shares Owned After
191,692.0
1. Sale of shares to cover the exercise price, withholding tax obligations and broker fees and commissions, pursuant to a broker assisted cashless exercise of vested stock options granted on January 8, 2021 and February 19, 2025 under the Carlsmed, Inc. 2019 Stock Incentive Plan.
2. This transaction was executed in multiple trades at prices ranging from $13.000 to $14.030. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
3. 25% of the shares underlying these options, representing a right to purchase a total of 358,422 shares, vested and became exercisable on December 15, 2021, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
4. 25% of the shares underlying these options, representing a right to purchase a total of 224,956 shares, vested and became exercisable on December 15, 2025, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.